Related Experiment Video
Updated: Jun 18, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.9K
Temporary Mechanical Circulatory Support in the Complex Vasculopath: Redefining What Is Possible.
Carly Lodewyks1, Joseph Karam2, Peter Eckman3
1Allina Health Minneapolis Heart Institute Section of Cardiac Surgery, Minneapolis, Minnesota, USA.
JACC. Case Reports
|October 31, 2025
Summary
Temporary mechanical circulatory support with Impella 5.5 enables complex procedures for patients with severe cardiomyopathy. This approach, combined with multidisciplinary care, improves outcomes for high-risk cardiovascular patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Mechanical Circulatory Support
Background:
- Severe cardiomyopathy presents significant challenges for complex cardiovascular interventions.
- Traditional risk stratification often excludes patients with severe cardiomyopathy from advanced procedures.
- Widespread vasculopathy further complicates management in these high-risk individuals.
Purpose of the Study:
- To evaluate the utility of temporary mechanical circulatory support in managing complex vasculopathy.
- To assess the feasibility of using Impella 5.5 in patients with severe cardiomyopathy undergoing major interventions.
- To highlight the importance of a multidisciplinary approach in optimizing outcomes.
Main Methods:
- A case report of a 64-year-old male with severe bicuspid aortic stenosis, coronary disease, cardiomyopathy, and widespread vascular disease.
- The patient underwent aortic valve replacement with direct aortic Impella 5.5 support.
- Subsequent procedures included Impella-supported percutaneous coronary intervention, carotid endarterectomy, and abdominal aortic aneurysm repair.
Main Results:
- Successful implementation of Impella 5.5 for a complex, multi-stage cardiovascular intervention.
- The patient tolerated multiple procedures, including aortic valve replacement and coronary intervention, under mechanical support.
- Completion of all planned interventions, including vascular repairs, prior to discharge.
Conclusions:
- Severe cardiomyopathy should not be considered a prohibitive risk for interventions with advanced mechanical circulatory support like Impella 5.5.
- Impella 5.5 facilitates complex procedures in high-risk patients with combined cardiac and vascular disease.
- Multidisciplinary team management is essential for achieving favorable outcomes in these complex cases.

